Dr Abdelrahman Taha

Dr Abdelrahman Taha spine physiotherapist...
Dedicated to improving outcomes and advancing spinal and compressive neuropathies rehabilitation.

Rethinking Spine Interventions: What the Evidence Actually Says 🩺Is it time to re-evaluate how we approach chronic spine...
27/04/2026

Rethinking Spine Interventions: What the Evidence Actually Says 🩺

Is it time to re-evaluate how we approach chronic spine pain? Recent moderate-certainty evidence suggests that many common interventional procedures may offer little to no benefit over sham treatments (placebos) for both pain relief and physical functioning. Here is a summary of the latest findings:

1. Chronic Axial Spine Pain:

For pain localized to the spine itself, moderate-certainty evidence shows:

👉 Epidural Injections: Whether using local anaesthetic alone or with steroids, there is little to no difference in pain relief compared to sham procedures.
👉 Joint-Targeted Injections: Steroid injections into the joints likely result in no significant difference in pain relief.
👉 Physical Functioning: Joint-targeted injections (with or without steroids) do not appear to improve physical function more than a sham procedure.

2. Chronic Radicular Spine Pain (Sciatica/Nerve Pain):

For pain radiating down the limbs, the results are similar:
👉 Epidural & Radiofrequency: Moderate-certainty evidence indicates that epidural steroid injections and radiofrequency of the dorsal root ganglion result in little to no difference in pain relief compared to sham.
👉 Functionality: Neither dorsal root ganglion radiofrequency nor epidural injections showed superior improvements in physical functioning over sham treatments.

💥 The Bottom Line:

While these procedures are frequently performed, the evidence suggests their specific therapeutic effect may be minimal for many patients:

1- Low Certainty: Evidence for other interventional procedures remains low or very low.

2- Safety Data: Evidence regarding adverse events is currently of low or very low certainty, highlighting a need for more robust safety reporting.

As the medical community shifts toward high-value care, these findings emphasize the importance of evidence-based practice and discussing the realistic expectations of interventional pain management with patients.

📉 Are Neurodynamic Tests Missing Severe Neuropathy in T1DM?Recent findings challenge how we interpret Straight Leg Raise...
25/04/2026

📉 Are Neurodynamic Tests Missing Severe Neuropathy in T1DM?

Recent findings challenge how we interpret Straight Leg Raise (SLR) and Slump tests for patients with Type 1 Diabetes Mellitus (T1DM) and Diabetic Peripheral Neuropathy (DPN). While these tests are staples for identifying nerve mechanosensitivity, the data suggests a "paradox": the worse the neuropathy, the less likely the test is to be positive.

📊 The Data: Test Outcomes by Proportion
Neurodynamic tests often return negative results in severe cases, potentially leading to a false sense of security during clinical assessment.

A) Straight Leg Raise (SLR) Results:
- Total Positive: 46% (Mostly Mild to Moderate DPN)
- Total Negative: 54% (Dominating the Severe DPN category at 35%)
- Key Insight: Zero participants with severe DPN had a positive SLR test.

B) Slump Test Results:
- Total Positive: 56% (Highest sensitivity in Mild cases at 30%)
- Total Negative: 44% (30% of these were individuals with severe DPN)

🔍 Does Severity Influence the Result?

Yes, significantly. The study found a clear inverse relationship between nerve damage and mechanosensitivity:

- The "Sensitivity Gap": Participants with negative SLR and Slump tests had significantly higher TCSS scores (indicating more severe neuropathy).

- The Mechanism: As DPN progresses to a severe stage, the nerve's ability to respond to mechanical stimuli (mechanosensitivity) may actually decrease or disappear, leading to a negative test result despite significant pathology.

💡 The Clinical Takeaway
If you are working with T1DM patients, remember: A negative SLR or Slump test does NOT rule out neuropathy. In fact, in the context of T1DM, a negative result may actually be a red flag for more severe nerve degeneration. These tests should be used to assess mechanosensitivity, but they are not reliable tools for determining the presence or absence of DPN.

Changing the way we look at Whiplash-Associated Disorder (WAD) II Traditional views often classify WAD II as purely musc...
24/04/2026

Changing the way we look at Whiplash-Associated Disorder (WAD) II

Traditional views often classify WAD II as purely musculoskeletal, but recent evidence suggests we are looking at a complex neuropathic and neuroinflammatory condition. For physiotherapists working in pain neuroscience, here is the breakdown of the latest findings on nerve pathology in whiplash:

1️⃣ It’s an Acute Nerve Injury:
Acute WAD II involves distinct structural pathology. Patients show elevated Neurofilament Light Chain (NfL)—a biomarker for acute axonal injury—alongside significant sensory hypoaesthesia. It’s not just "sore muscles"; it's neural tissue distress.

2️⃣ Peripheral Neuroinflammation is Real:
MRI studies reveal increased T2-weighted signals in the C5 nerve root and Dorsal Root Ganglia (DRG). This indicates intraneural edema and widespread peripheral neuroinflammation, coinciding with systemic spikes in IFN-y, IL-6, and IL-8.

3️⃣ The Chronic Paradox:
In chronic stages, we see localized skin inflammation (elevated TNF mRNA at the finger) and reduced nerve fiber density. Interestingly, these don't always correlate directly with pain severity, suggesting that local inflammation and nerve loss follow complex, independent paths.

4️⃣ Recovery is a Mixed Bag:
At 6 months, axonal damage markers (NfL) may normalize, but the "hidden" pathology remains:

-75% of patients still exhibit sensory hypoaesthesia.

- MRI neuroinflammation signals often remain unaltered.

- Dermal myelinated nerve bundles show structural reduction.

5️⃣ Clinical Prediction: The "Bedside" Advantage
We don’t need an MRI to predict who will struggle. Simple bedside tests are powerful prognostic indicators for persistent pain:

✅ Sensory testing: Assessing for hypoaesthesia at the index finger.

✅ Neurodynamics: Measuring reduced range of motion (e.g., elbow extension) during nerve tension tests.

The Takeaway: Targeted neuropathic management should be considered early. If we only treat the "muscle," we miss the "nerve."

Is Chronic Whiplash More Than Just a "Neck Issue"?New research is pulling back the curtain on the hidden biology of Whip...
24/04/2026

Is Chronic Whiplash More Than Just a "Neck Issue"?

New research is pulling back the curtain on the hidden biology of Whiplash-Associated Disorder (WAD) Grade II. While we often focus on the joints and muscles, the secret to chronic pain might actually be hiding in the skin.

A recent exploratory study looked at why some patients with WAD II show neurological symptoms, specifically reduced intra-epidermal nerve fiber density (IENFD)—essentially, a thinning of the tiny nerve endings in the skin.

🔍 The Key Findings:

1) The TNF Factor: Researchers found that TNF mRNA expression (a pro-inflammatory marker) was nearly twofold higher in the finger skin of chronic WAD patients compared to healthy controls.
2) Location Matters: Interestingly, this inflammatory spike was found at the finger, but not at the ankle, suggesting a localized peripheral involvement in the upper limb.
3) The Missing Link: Despite the increase in inflammation, there wasn't a direct correlation between cytokine levels and the actual density of nerve fibers or the patient's reported pain levels.

💡 What does this mean for Clinicians?
This suggests that chronic whiplash involves a complex local skin inflammatory process. While we can't yet draw a straight line from cytokine expression to clinical disability, it confirms that WAD is a multisystem condition. The "invisible" pain of whiplash is becoming more visible under the microscope. We are moving away from seeing WAD as purely mechanical and moving toward a neuro-immunological understanding of persistent pain.

The "Diagnostic Chameleon": Deciphering Spine-Related Arm Pain (SAP) 🦴⚡️Arm pain is rarely just "arm pain." It often act...
24/04/2026

The "Diagnostic Chameleon": Deciphering Spine-Related Arm Pain (SAP) 🦴⚡️

Arm pain is rarely just "arm pain." It often acts as a clinical mask for complex processes occurring in the cervical spine or spinal nerves.
For primary care clinicians, Spine-Related Arm Pain (SAP) represents a significant diagnostic challenge. Between overlapping dermatomal patterns, evolving symptoms, and the "noise" of non-specific musculoskeletal disorders, how do we accurately stratify risk and identify the underlying pain mechanism?

🔍 Moving Beyond Local Symptoms
A recent framework proposes a structured, consensus-based guide to help clinicians navigate this complexity. Instead of relying on intuition, the guide advocates for "mechanism-based reasoning"—integrating the latest terminology from the "International Association for the Study of Pain (IASP)" and the "NeuPSIG" recommendations.

🛠 The SAP Diagnostic Algorithm
The proposed algorithm focuses on three critical pillars:
1- Mechanistic Descriptors: Classifying pain based on whether it is nociceptive, neuropathic, or nociplastic.
2- Mandatory Neurological Examination: Moving beyond basic strength testing to include sensory mapping and neurodynamic tension tests.
3- Safety-Netting & Stratification: Identifying "Red Flags" early while managing the evolving nature of spinal pathology.

📖 From Theory to Practice
The framework is illustrated through three clinical scenarios, demonstrating how to integrate subjective history with objective clinical findings. This isn't just about finding a diagnosis; it’s about improving clinical confidence and ensuring patient safety through ongoing monitoring.

💡 Why This Matters for Clinicians
Whether you are an experienced practitioner or an early-career clinician, transitioning from "where it hurts" to "why it hurts" is the key to effective management. Pragmatic knowledge-translation tools like this algorithm bridge the gap between complex neuroscience and the fast-paced environment of primary care.

I am truly honored and excited to announce that I will be delivering an online lecture at the General Physical Therapy S...
24/04/2026

I am truly honored and excited to announce that I will be delivering an online lecture at the General Physical Therapy Syndicate of Egypt. 🇪🇬

Being part of such a prestigious institution is a milestone I cherish. I firmly believe that our core mission is to share knowledge and act as a guiding light for our colleagues, working together to elevate the standards of our beloved profession in Egypt.

Topic: Entrapment Neuropathies: How We Assess & How We Treat
In this session, we will dive deep into:
• Recognizing Phenotypic Diversity: Understanding the varied clinical presentations of peripheral nerve compression.
• Critical Evaluation of Diagnostics: Analyzing the utility and limitations of conventional clinical assessments.
• Beyond Standard Algorithms: Discussing why standardized treatments sometimes fail and how to improve our clinical outcomes.
Language: The lecture will be conducted in a mix of Arabic (Egyptian Dialect) and English to ensure the information is both accessible and scientifically rigorous.

To my dear colleagues across the Arab world: 🌍
Since this is an online event, you are more than welcome to join us! If you are interested in attending, I will be happy to share the registration link with you: https://chat.whatsapp.com/JE88Ei8pIB5Lmg6LKRPKN0?mode=gi_t

I hope this session leaves a lasting positive impact on our clinical practice. See you there! 💡

Neurofilament Light (NfL): Bridging the Gap Between Nociplastic and Neuropathic PainIs Fibromyalgia purely nociplastic? ...
16/04/2026

Neurofilament Light (NfL): Bridging the Gap Between Nociplastic and Neuropathic Pain

Is Fibromyalgia purely nociplastic? Recent evidence suggests we might need to rethink that classification. A recent study characterizing Neurofilament light (NfL)—a sensitive biomarker for axonal injury—across the pain spectrum offers some compelling insights into the "invisible" pathology of chronic pain.

The Comparison: NfL Levels Across Conditions
The study compared NfL concentrations in Small Fiber Neuropathy (SFN), Fibromyalgia (FM), Endometriosis, and healthy controls:

- Fibromyalgia & SFN: Both groups showed significantly elevated serum NfL compared to controls. This suggests that FM, much like a recognized neuropathy (SFN), involves ongoing axonal injury despite the symptoms being chronic (median duration >4 years).

- Endometriosis: Displayed an intermediate phenotype. While absolute concentrations were similar to controls, NfL z-scores were significantly elevated, echoing the lower (but present) prevalence of neural injury in this group.

- Key Insights for Clinical Reasoning

👉Challenging the "Purely Nociplastic" Label: The presence of structural and functional nerve pathology in FM suggests that nociplastic, neuropathic, and nociceptive mechanisms frequently coexist.

👉Neuropathic-like Pain: Using the painDETECT questionnaire, neuropathic-like pain was identified in 44% of FM and 26% of Endometriosis participants.

👉The Immune Connection: Hypotheses point toward immune-mediated mechanisms, where IgG may sensitize nociceptive afferents, potentially driving the loss of intraepidermal nerve fiber density.

👉 Activity Matters: Interestingly, physical activity may modulate these changes. Evidence suggests supervised exercise can actually increase nerve fiber density in FM patients over time.

The Clinical "So What?"
While NfL variability currently limits its use as a standalone diagnostic tool for individual patients, these findings advocate for a stratified approach. Recognizing the neuropathic components within conditions like Fibromyalgia allows us to move away from "one-size-fits-all" labels and toward more targeted, personalized treatments.

The Lumbar Facet Syndrome: Myth or Reality? While the lumbar facet joint is a biomechanical powerhouse protecting our di...
16/04/2026

The Lumbar Facet Syndrome: Myth or Reality?

While the lumbar facet joint is a biomechanical powerhouse protecting our discs from torsion, its role as a primary pain generator remains controversial. A comprehensive review of the literature and clinical studies suggests that "Facet Syndrome" is not a reliable clinical diagnosis, as symptoms are often non-specific and overlap with discogenic pain. Interestingly, intraarticular saline injections proved as effective as steroids for temporary relief, indicating a significant placebo effect. Furthermore, a patient’s response to these injections does not predict the success of future spinal fusions. For clinicians, the takeaway is clear: focus on loading the facets to spare the discs, but remain cautious of over-diagnosing the joint itself as the sole source of chronic low back pain. That's why double blocks appear in era of facetogenic, SIJ....etc mediated pain diagnosis.

Lumbar Facet Syndrome: Clinical Pathophysiology and Diagnostic RealitiesThis summary distills the 1976 study by Mooney a...
16/04/2026

Lumbar Facet Syndrome: Clinical Pathophysiology and Diagnostic Realities

This summary distills the 1976 study by Mooney and Robertson regarding the zygapophyseal joints as a primary source of "pseudo-radicular" symptoms.

The Clinical Pattern: Facetogenic "Sciatica"
Experimental irritation of the facet joint capsule via hypertonic saline produces a pain referral pattern that is clinically indistinguishable from discogenic syndrome.
- Primary Distribution: Pain typically localizes in the low back and greater trochanter, radiating down the posterior-lateral thigh.
- Distal Radiation: In symptomatic patients, irritation can cause pain to radiate into the entire leg and foot.
- Segmental Variation: L3-4 joints generally refer pain to the lateral aspect of the leg, while L4-5 and L5-S1 patterns are more posterior and difficult to differentiate from one another.
- Myoelectric Response: Irritation triggers marked myoelectric activity in the hamstrings, often resulting in a protective "hitch" during movement.

👉 Clinical Synthesis for Physiotherapy
The study concludes that unless definitive neurological deficits (sensory/motor loss) are present, pain complaints cannot specifically localize the site of abnormality. The therapeutic value of a facet block is not the injection itself, but the resulting "pharmacological remission" that allows the patient to engage in a progressive physical exercise program to address underlying instability or degenerative changes.

Dorsal Primary Ramus Entrapment: Is Local Back Pain a Neuropathic Phenomenon?Marshall Devor has suggested (Devor 1996 & ...
16/04/2026

Dorsal Primary Ramus Entrapment: Is Local Back Pain a Neuropathic Phenomenon?

Marshall Devor has suggested (Devor 1996 & 1999) that local (either central or unilateral) back pain may be the result of dorsal primary ramus entrapment. Recollection of the anatomic course of these nerves would suggest they are vulnerable to compression during extension like maneuvers.

It be possible that the increased back pain noted and which is often difficult to relieve is in fact, a "neuropathic phenomenon"! (Alrowayeh et al. 2010; Schmidt et al., n.d.).

References:
- Alrowayeh, H. N., & Sabbahi, M. A. (2010). The proportion of patients with non-specific low back pain and neural compromise. Electromyography and clinical neurophysiology, 50(2), 67–73.
- Devor M. (1999) Unexplained Perculiarities of the Dorsal Root Ganglion. Pain Supplement 6:S21-S27.
- Devor M. (1996) Pain Mechanisms and Pain Syndromes in Campbell J.N.(ed) Pain 1996 - An Updated Review. IASP Press. Seattle.
- Schmid, A. B., & Tampin, B. (n.d.). Section 10, chapter 10: Spinally referred back and leg pain. In Wheeless' textbook of orthopaedics. International Society for the Study of the Lumbar Spine. https://www.wheelessonline.com/issls/section-10-chapter-10-spinally-referred-back-and-leg-pain

Centralization is one of the most powerful prognostic indicators in spinal rehab. But Robin McKenzie’s observations go f...
13/04/2026

Centralization is one of the most powerful prognostic indicators in spinal rehab. But Robin McKenzie’s observations go far beyond the classic "distal-to-proximal" textbook definition. If you are treating spinal pain or spinal-related lower extremity symptoms, symptom behavior during mechanical evaluation tells a detailed story. Here is a breakdown of what we actually see in the clinic during the centralization process:

🔄 1. The Classic Progression We all know this one: pain retreats from the distal extremities (like the lower leg) and moves proximally until only central low back pain remains. But remember, centralization can also mean distal pain completely vanishes and *reappears* in a previously pain-free proximal zone.

⚡ 2. Rapid Abolition (No Centralization Required)
Sometimes, symptoms simply stop. Function is spontaneously and immediately recovered without the gradual distal-to-proximal retreat. This is most common when pain is exclusively in the back, or immediately following specific interventions.

🔙 3. The "Reversible" Clue
What happens when pain ceases, but returns after an opposing movement? If the returning pain doesn't radiate as far down the leg as the original symptom, the *process* of centralization is actively occurring.

⏱️ 4. Timelines & Natural History
Centralization can happen in a single session or take 2-3 weeks in severe radiating cases.

- Pro Tip: Wondering if a slow recovery is just natural history? Test the directional preference. If opposing movements (like repeated flexion) rapidly worsen the pain, and extension rapidly resolves it again—you are driving a mechanical response, not just waiting on time.

Understanding these nuances helps us avoid prematurely abandoning a successful loading strategy!

🔍 Does MRI Progression Actually Correlate with Back Pain Disability?We often debate in clinical practice whether structu...
13/04/2026

🔍 Does MRI Progression Actually Correlate with Back Pain Disability?

We often debate in clinical practice whether structural spine changes seen on MRIs are merely incidental or true drivers of patient symptoms. A compelling 4-year longitudinal study involving 561 young adults (18–40 yrs) with Low Back Pain (LBP) provides crucial insights into how whole-spine MRI progression correlates with clinical disability. Researchers tracked the evolution of vertebral endplate signal changes (VESC), disc degeneration, and disc herniations over a four-year period, comparing them against changes in patient disability (using the Roland Morris Disability Questionnaire). Here is what the data revealed about the structural evolution of the spine:

1- The Big Picture Matters: The association between MRI progression and clinical disability heavily depends on data aggregation—specifically, the anatomical extent, number, and severity of the findings.

2- Isolated Findings Lack Impact: When structural changes were analyzed in strict isolation or by specific regional levels, only a few distinct associations with changes in disability were observed.

3- Whole-Spine Progression is Key: Broader measures that incorporated cumulative, whole-spine findings (summarized as continuous or binary variables) showed a clear association with changes in clinical disability.

The Clinical Takeaway: Structural progression across the spine plays a contributory, clinically relevant role in LBP-related disability. These findings urge us to look beyond isolated, single-level regional changes and consider the cumulative, whole-spine structural burden when assessing patient prognosis.

Address

السويس
Suez

Alerts

Be the first to know and let us send you an email when Dr Abdelrahman Taha posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Dr Abdelrahman Taha:

Share